Our goal is to build an international biopharmaceutical company developing and commercializing new therapies for oncology and rare diseases based on novel targets with strong scientific and biological rationale. We seek to commercialise some of our therapeutics in certain regions and indications and to partner where significantly more resources are needed to fully exploit the potential of the target.